Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.8 - $7.25 $66,518 - $100,470
-13,858 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$16.01 - $34.69 $112,422 - $243,593
7,022 Added 102.72%
13,858 $399,000
Q1 2020

May 13, 2020

BUY
$14.53 - $30.69 $1,147 - $2,424
79 Added 1.17%
6,836 $147,000
Q4 2019

Feb 14, 2020

BUY
$9.32 - $19.68 $62,975 - $132,977
6,757 New
6,757 $133,000

About Satsuma Pharmaceuticals, Inc.


  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.